 Todos Medical Ltd told investors it was seeking a New York Stock Exchange listing and revealed it is in the final stages of launching a crowdfunding campaign for its subsidiary 3CL Pharma and its Long COVID trials of Tollovir and Tollovid. In a wide-ranging corporate update, the New York- and Tel Aviv-based diagnostics company said that it had received significant interest from institutional investors and not-for-profit organizations in trials for Tollovir in Long COVID. 